Dr Ashenafi Betrie
PhD, MSc, BPharm

Dr. Betrie finished his PhD in Cardiovascular Pharmacology from the University of Melbourne in 2018. During his PhD, he investigated the roles of transition metals, particularly zinc, in the cardiovascular system and discovered a new class of compounds that alter vascular tone regulation. His work was presented in national meetings and was invited to talk in two international conferences. He is currently investigating the vascular and neurovascular physiological and pharmacological mechanisms of metal-based compounds in his postdoctoral research position in the oxidation biology group of the Melbourne Dementia Research Center.

Key collaborators:

A/Prof Daniel Scott and Dr Alaa Abdul-Ridha at Receptor Structure and Drug Discovery Laboratory, The Florey Institute of Neuroscience and Mental Health

A/Prof Chrsitine Wright and Emeritus Prof. James Angus at the Cardiovascular Therapeutics Unit, Department of Biochemistry and Pharmacology, University of Melbourne

A/Prof James Brock at the Department of Anatomy and Physiology, University of Melbourne

Prof Guo-Wei He at the TEDA International Cardiovascular Hospital, Tianjin, China